Detection of ERG11 Point Mutations in Iranian Fluconazole-resistant Isolates

Overview

Journal Curr Med Mycol

Date 2019 May 4

PMID 31049452

Citations 8

Authors

Ali Sardari

Hossein Zarrinfar

Rasoul Mohammadi

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Candidiasis is referred to a group of superficial and deep-tissue fungal infections often caused by The superficial infections affect the oral, oropharynx, esophagus, and vaginal mucosa The treatment of choice for these infections is the use of azoles, such as fluconazole. However, the increased use of these antifungal agents has led to the emergence of azole-resistant isolates of . Different mechanisms have been suggested for the development of drug resistance, such as mutations in the encoding gene . Mutations in result in changes in the ERG11p spatial construction and reduce the affinity between the protein and azole. This study aimed to determine the susceptibility profile of clinical isolates to fluconazole using microdilution method. The present research was also targeted toward the detection of mutations that might be related to fluconazole resistance by the amplification and sequencing of 11 gene.

Materials And Methods: This study was conducted on a total of 216 clinical isolates obtained from Mashhad, Isfahan, and Tehran cities in Iran, during 2016-2018. The clinical isolates were identified using molecular techniques. Furthermore, minimum inhibitory concentration (MICs) was determined according to the clinical and laboratory standards institute M27-A3 and M27-S4 documents. The concentration range for fluconazole was obtained as 0.063-64 μg/ml. In the resistant strains, 11 genes were amplified by specific primers. Subsequently, cycle sequencing reactions were performed on purified polymerase chain reaction (PCR) products in forward and reverse directions. Finally, the results were analyzed by MEGA (version 7) and Gene Runner software (version 6.5.30).

Results: Out of 216 strains, 100 (46.3%) species were identified as . The MIC values for fluconazole had a range of 0.125-16 μg/ml with the MIC50 and MIC90 values of 0.5 and 1 μg/ml, respectively. Totally, 41 nucleotide changes were detected among 4 resistant isolates. In this regard, 4 out of 41 mutations in codons caused changes in ERG11p; however, these mutations did not lead to fluconazole resistance.

Conclusion: Fluconazole resistance among clinical isolates is not merely due to the changes in ERG11p. This resistance may be also related to some other mechanisms, such as the prevention of the intracellular accumulation of the antifungal agent and alteration of the target enzyme to diminish drug binding.

Citing Articles

Sequential Induction of Drug Resistance and Characterization of an Initial Drug-Sensitive Isolate.

Hachem S, Fattouh N, Chedraoui C, Finianos M, Bitar I, Khalaf R J Fungi (Basel). 2024; 10(5).

PMID: 38786702 PMC: 11122215. DOI: 10.3390/jof10050347.

Antifungal activity of three different varieties of Capsicum annuum against clinical isolates of Candida species.

Moghadam S, Azari B, Rashidi R, Hosseini Bafghi M, Rakhshandeh H, Selman S Trop Dis Travel Med Vaccines. 2023; 9(1):9.

PMID: 37468970 PMC: 10357713. DOI: 10.1186/s40794-023-00194-w.

Analysis of molecular resistance to azole and echinocandin in species in patients with vulvovaginal candidiasis.

Lotfali E, Erami M, Fattahi M, Nemati H, Ghasemi Z, Mahdavi E Curr Med Mycol. 2023; 8(2):1-7.

PMID: 36654793 PMC: 9825790. DOI: 10.18502/cmm.8.2.10326.

Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species.

Azari B, Zahmatkesh Moghadam S, Zarrinfar H, Tasbandi A, Jamialahmadi T, Sahebkar A Adv Exp Med Biol. 2022; 1328:123-129.

PMID: 34981474 DOI: 10.1007/978-3-030-73234-9_8.

The A756T Mutation of the Gene Associated With Resistance to Itraconazole in Isolated From Mycotic Mastitis of Cows.

Du J, Ma W, Fan J, Liu X, Wang Y, Zhou X Front Vet Sci. 2021; 8:634286.

PMID: 34458346 PMC: 8385537. DOI: 10.3389/fvets.2021.634286.

References

Asai K, Tsuchimori N, OKONOGI K, Perfect J, Gotoh O, Yoshida Y . Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Antimicrob Agents Chemother. 1999; 43(5):1163-9. PMC: 89127. DOI: 10.1128/AAC.43.5.1163. View

Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W . Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (Reading). 1999; 145 ( Pt 10):2701-2713. DOI: 10.1099/00221287-145-10-2701. View

Lamb D, Kelly D, White T, Kelly S . The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother. 1999; 44(1):63-7. PMC: 89629. DOI: 10.1128/AAC.44.1.63-67.2000. View

Kakeya H, Miyazaki Y, Miyazaki H, Nyswaner K, Grimberg B, Bennett J . Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob Agents Chemother. 2000; 44(11):2985-90. PMC: 101590. DOI: 10.1128/AAC.44.11.2985-2990.2000. View

St-Germain G, Laverdiere M, Pelletier R, Bourgault A, Libman M, Lemieux C . Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol. 2001; 39(3):949-53. PMC: 87855. DOI: 10.1128/JCM.39.3.949-953.2001. View

Perea S, Lopez-Ribot J, Kirkpatrick W, McAtee R, Santillan R, Martinez M . Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001; 45(10):2676-84. PMC: 90716. DOI: 10.1128/AAC.45.10.2676-2684.2001. View

White T, Holleman S, Dy F, Mirels L, Stevens D . Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother. 2002; 46(6):1704-13. PMC: 127245. DOI: 10.1128/AAC.46.6.1704-1713.2002. View

Maebashi K, Kudoh M, Nishiyama Y, Makimura K, Uchida K, Mori T . A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient. Microbiol Immunol. 2002; 46(5):317-26. DOI: 10.1111/j.1348-0421.2002.tb02702.x. View

Maebashi K, Kudoh M, Nishiyama Y, Makimura K, Kamai Y, Uchida K . Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient. Microbiol Immunol. 2003; 47(2):117-24. DOI: 10.1111/j.1348-0421.2003.tb02794.x. View

10.

Li X, Brown N, Chau A, Lopez-Ribot J, Ruesga M, Quindos G . Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 2003; 53(1):74-80. DOI: 10.1093/jac/dkh027. View

11.

Goldman G, da Silva Ferreira M, Marques E, Savoldi M, Perlin D, Park S . Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. Diagn Microbiol Infect Dis. 2004; 50(1):25-32. DOI: 10.1016/j.diagmicrobio.2004.04.009. View

12.

Coste A, Karababa M, Ischer F, Bille J, Sanglard D . TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell. 2004; 3(6):1639-52. PMC: 539021. DOI: 10.1128/EC.3.6.1639-1652.2004. View

13.

Kamai Y, Maebashi K, Kudoh M, Makimura K, Naka W, Uchida K . Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis. Microbiol Immunol. 2004; 48(12):937-43. DOI: 10.1111/j.1348-0421.2004.tb03623.x. View

14.

MacPherson S, Akache B, Weber S, De Deken X, Raymond M, Turcotte B . Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother. 2005; 49(5):1745-52. PMC: 1087678. DOI: 10.1128/AAC.49.5.1745-1752.2005. View

15.

Park S, Perlin D . Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb Drug Resist. 2005; 11(3):232-8. DOI: 10.1089/mdr.2005.11.232. View

16.

Wang Y, Wang H, Guo H, Zhao Y, Luo S . [Analysis of ERG11 gene mutation in Candida albicans]. Di Yi Jun Yi Da Xue Xue Bao. 2005; 25(11):1390-3. View

17.

Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V . Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect. 2006; 12(1):75-80. DOI: 10.1111/j.1469-0691.2005.01310.x. View

18.

Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H . A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi. 2006; 47(3):225-9. DOI: 10.3314/jjmm.47.225. View

19.

Akbar D, Tahawi A . Candidemia at a University Hospital: epidemiology, risk factors and predictors of mortality. Ann Saudi Med. 2007; 21(3-4):178-82. DOI: 10.5144/0256-4947.2001.178. View

20.

Xu Y, Chen L, Li C . Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J Antimicrob Chemother. 2008; 61(4):798-804. DOI: 10.1093/jac/dkn015. View